Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.1K Buy
670
+5
+0.8% +$585 0.09% 68
2026
Q1
$80K Buy
665
+5
+0.8% +$577 0.1% 72
2025
Q4
$69.5K Buy
660
+5
+0.8% +$469 0.08% 80
2025
Q3
$55K Buy
+655
New +$53.9K 0.07% 89
2025
Q2
Sell
-704
Closed -$63.2K 175
2025
Q1
$63.2K Buy
704
+5
+0.7% +$467 0.09% 79
2024
Q4
$69.5K Buy
699
+5
+0.7% +$515 0.1% 80
2024
Q3
$78.8K Buy
694
+4
+0.6% +$475 0.12% 77
2024
Q2
$85.4K Buy
690
+72
+12% +$9.27K 0.13% 73
2024
Q1
$81.6K Buy
618
+3
+0.5% +$370 0.13% 76
2023
Q4
$67K Buy
+615
New +$63.8K 0.11% 75

Other funds holding MRK

Wiser Advisor Group's MRK Position: Q2 2026 in Review

Wiser Advisor Group increased its Merck (MRK) stake by 0.75% in Q2 2026, buying an estimated $585 and bringing the position to 670 shares worth $86.1K. The position accounts for 0.09% of the portfolio, ranked #68.

Wiser Advisor Group first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wiser Advisor Group held 670 shares of Merck worth $86.1K as of Q2 2026.
  • Wiser Advisor Group bought 5 Merck shares in Q2 2026, an estimated $585.
  • Merck made up 0.09% of Wiser Advisor Group's portfolio in Q2 2026, its #68 holding.
  • Wiser Advisor Group first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wiser Advisor Group's 13F filing for Q2 2026, filed 17 Aug 2026.